S. ÜNAL Et Al. , "Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major," 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.128, California, United States Of America, 2016
ÜNAL, S. Et Al. 2016. Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major. 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (California, United States Of America).
ÜNAL, S., Kalkan, N., ÇETİN, M., & GÜMRÜK, F., (2016). Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major . 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America
ÜNAL, SERHAT Et Al. "Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major," 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 2016
ÜNAL, SERHAT Et Al. "Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , California, United States Of America, 2016
ÜNAL, S. Et Al. (2016) . "Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , California, United States Of America.
@conferencepaper{conferencepaper, author={SERHAT ÜNAL Et Al. }, title={Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major}, congress name={58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={California}, country={United States Of America}, year={2016}}